Form 4 for BEAM Beam Therapeutics Inc.

Accepted 2021-08-10 00:00:00 ET · period of report 2021-08-06 · accession 0000315066-21-001699 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X	Filed	Traded	Ticker	Insider	Title	Type	Price	Qty	Owned	ΔOwn	Value
MI	2021-08-10	2021-08-06+	BEAM	FMR LLC	See Remark 1	J - Other	$0.00	-1.46M	0	-100%	$0

Purchase Sale Sale after option exercise All abbreviations

#	Table	Security	Date	Code	A/D	Shares	Price	Owned after	Own	Exercise / expiry	Underlying	Footnotes
1	Common	Common Stock	2021-08-06	J	D	745,393	$0.00	6,226,519	I F-Prime Capital Partners Healthcare Fund V LP	—	—	(F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
2	Common	Common Stock	2021-08-06	J	A	7,454	$0.00	7,454	I F-Prime Capital Partners Healthcare Advisors Fund V LP	—	—	(F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
3	Common	Common Stock	2021-08-09	J	D	1,160,430	$0.00	153	I Impresa Fund III Limited Partnership	—	—	(F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
4	Common	Common Stock	2021-08-06	J	A	724	$0.00	724	I F-Prime Inc.	—	—	(F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
5	Common	Common Stock	2021-08-06	J	A	447,236	$0.00	1,160,583	I Impresa Fund III Limited Partnership	—	—	(F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.
6	Common	Common Stock	2021-08-06	J	D	7,454	$0.00	0	I F-Prime Capital Partners Healthcare Advisors Fund V LP	—	—	(F1) These holdings were acquired or disposed of (as applicable) in the form of a distribution without payment of consideration.